| Literature DB >> 35899057 |
Som P Singh1, Fahad M Qureshi1, Kiera G Borthwick2, Sagar Singh1, Shreya Menon1, Brandon Barthel1.
Abstract
Introduction: The internet is an ever-evolving resource to improve healthcare literacy among patients. The nature of the internet can make it difficult to condense educational materials in a manner applicable to a worldwide patient audience. Within the realm of endocrinology, there is lack of a comprehensive analysis regarding these pathologies in addition to education materials related to their medical work-up or management. The aim of this study was to assess contemporary online patient education material in endocrinology and management of care.Entities:
Keywords: adrenal glands; diabetes mellitus; patient education; readability; thyroid
Year: 2022 PMID: 35899057 PMCID: PMC9311631 DOI: 10.17161/kjm.vol15.16529
Source DB: PubMed Journal: Kans J Med ISSN: 1948-2035
Endocrine-related content areas of interest.
| Adrenal | Diabetes | Thyroid |
|---|---|---|
| Addison’s Disease | Type 1 Diabetes | Graves’ Disease |
| Cushing’s Disease | Type 2 Diabetes | Hashimoto’s Thyroiditis |
| Cushing’s Syndrome | Insulin | Thyroid Hormone |
| Conn’s Syndrome & Hyperaldosteronism | Metformin | Thyroid Cancer |
| Congenital Adrenal Hyperplasia | Dipeptidyl Peptidase-4 (DPP-4) Inhibitor | Goiter |
| Pheochromocytoma | Sodium/Glucose Cotransporter (SGLT-2) Inhibitor | Levothyroxine |
| Multiple Endocrine Neoplasia | Insulin Pumps | Hypothyroidism |
| Neuroblastoma | Sulfonylureas | Hyperthyroidism |
| Paraganglioneuroma | Diabetic Ketoacidosis | Thyroid Biopsy |
| Hirsutism | Maturity Onset Diabetes of the Young | Thyroid and Iodine |
Average grade reading levels across categories.
| Content of Education Materials | Average Grade Reading Level | Confidence Intervals |
|---|---|---|
| Diabetes-Related | 13.54 | (CI: 13.08 – 14.00) |
| Thyroid-Related | 12.91 | (CI: 12.56 – 13.26) |
| Adrenal-Related | 12.78 | (CI: 12.34 – 13.22) |
|
|
|
|
| Diabetes-Related | 40.29 (“difficult to read”) | (CI: 34.45 – 46.13) |
| Thyroid-Related | 39.82 (“difficult to read”) | (CI: 36.43 – 43.21) |
| Adrenal-Related | 32.57 (“difficult to read”) | (CI: 28.17 – 36.97) |
Reading level analysis of adrenal-related educational material.
| Content Related To: | Grade Reading Level | Confidence Interval |
|---|---|---|
| Paraganglioneuroma | 16.45 | (CI: 15.01 – 17.89) |
| Conn’s Syndrome | 14.74 | (CI: 14.30 – 15.18) |
| Congenital Adrenal Hyperplasia | 14.48 | (CI: 14.05 – 14.91) |
| Pheochromocytoma | 14.22 | (CI: 13.81 – 14.63) |
| Multiple Endocrine Neoplasia | 13.94 | (CI: 13.58 – 14.30) |
| Cushing’s Disease | 13.18 | (CI: 13.14 – 13.22) |
| Addison’s Disease | 13.16 | (CI: 12.84 – 13.48) |
| Cushing’s Syndrome | 13.12 | (CI: 12.77 – 13.46) |
| Neuroblastoma | 12.18 | (CI: 11.84 – 12.54) |
Average Flesch Reading Ease measurements of adrenalrelated education materials.
| Content Related To: | Flesch Reading Ease Measurement | Confidence Intervals |
|---|---|---|
| Addison’s Disease | 45.07 (“difficult”) | (CI: 30.76 – 39.38) |
| Neuroblastoma | 42.81 (“difficult”) | (CI: 38.54 – 47.08) |
| Hirsutism | 38.94 (“difficult”) | (CI: 33.75–44.13) |
| Cushing’s Disease | 37.11 (“difficult”) | (CI: 32.96 – 41.25) |
| Multiple Endocrine Neoplasia | 33.73 (“difficult”) | (CI: 29.87 – 37.59) |
| Congenital Adrenal Hyperplasia | 29.32 (“very difficult”) | (CI: 23.77 – 34.87) |
| Pheochromocytoma | 26.07 (“very difficult”) | (CI: 20.58–31.55) |
| Paraganglioneuromas | 23.11 (“very difficult”) | (CI: 17.76 – 28.45) |
| Conn’s Syndrome | 21.97 (“very difficult”) | (CI: 16.55 – 27.40) |
Average grade reading level of diabetes-related educational material.
| Content Related To: | Grade Reading Level | Confidence Interval |
|---|---|---|
| Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors | 14.70 | (CI: 14.33 – 15.08) |
| Sulfonylureas | 13.87 | (CI: 12.99 – 14.76) |
| Maturity Onset Diabetes of the Young | 13.54 | (CI: 13.15 – 13.93) |
| Metformin | 13.33 | (CI: 12.96 – 13.71) |
| DPP-4 Inhibitors | 13.29 | (CI: 12.88 – 13.70) |
| Type 2 Diabetes | 12.04 | (CI: 11.10 – 12.99) |
| Insulin | 12.03 | (CI: 11.67 – 12.39) |
| Insulin Pumps | 11.91 | (CI: 11.56 – 12.26) |
| Diabetic Ketoacidosis | 11.61 | (CI: 11.26 – 11.96) |
| Type 1 Diabetes | 11.15 | (CI: 11.85 – 11.45) |
Average Flesch Reading Ease measurements of diabetesrelated education materials.
| Content Related To: | Flesch Reading Ease Measurement | Confidence Interval |
|---|---|---|
| Type 1 Diabetes | 52.28 (“fairly difficult”) | (CI: 48.52 – 56.03) |
| Type 2 Diabetes | 49.46 (“difficult”) | (CI: 46.35 – 52.58) |
| Insulin pumps | 48.30 (“difficult”) | (CI: 43.94 – 52.67) |
| Insulin | 47.32 (“difficult”) | (CI: 44.07 – 50.58) |
| Diabetic Ketoacidosis | 44.91 (“difficult”) | (CI: 40.44 – 49.41) |
| Metformin | 38.71 (“difficult”) | (CI: 34.36 – 43.06) |
| Maturity Onset Diabetes of the Young | 34.69 (“difficult”) | (CI: 30.51 – 38.87) |
| DPP-4 Inhibitors | 32.92 (“very difficult”) | (CI: 28.98 – 36.86) |
| Sulfonylureas | 28.17 (“very difficult”) | (CI: 24.25 – 37.59) |
| SGLT2 Inhibitors | 26.10 (“very difficult”) | (CI: 22.80 – 29.39) |
Average grade reading level of thyroid-related educational material.
| Content Related To: | Grade Reading Level | Confidence Interval |
|---|---|---|
| Hyperthyroidism | 13.73 | (CI: 13.29 – 14.17) |
| Graves’ Disease | 13.18 | (CI: 12.84 – 13.52) |
| Levothyroxine | 12.97 | (CI: 12.52 – 13.43) |
| Hashimoto’s Thyroiditis | 12.92 | (CI: 12.58 – 13.26) |
| Thyroid and Iodine | 12.91 | (CI: 12.51 – 13.30) |
| Thyroid Hormone | 12.48 | (CI: 12.14 – 12.82) |
| Hypothyroidism | 12.44 | (CI: 12.13 – 12.75) |
| Goiter | 11.61 | (CI: 11.32 – 11.89) |
| Thyroid Cancer | 11.36 | (CI: 11.04 – 11.68) |
| Thyroid Biopsy | 11.20 | (CI: 10.86 – 11.54) |
Average Flesch Reading Ease of thyroid-related content.
| Content Related To: | Flesch Reading Ease Measurement | Confidence Interval |
|---|---|---|
| Thyroid Cancer | 47.95 (“difficult to read”) | (CI: 44.20 – 51.70) |
| Thyroid Biopsy | 47.80 (“difficult”) | (CI: 43.43 – 52.16) |
| Goiter | 45.98 (“difficult”) | (CI: 42.50 – 49.46) |
| Thyroid Hormone | 39.11 (“difficult”) | (CI: 35.23 – 42.99) |
| Thyroid and Iodine | 38.35 (“difficult”) | (CI: 33.82 – 42.88)) |
| Grave’s Disease | 37.81 (“difficult”) | (CI: 33.83 – 41.79) |
| Hypothyroidism | 37.51 (“difficult”) | (CI: 33.64 – 41.39) |
| Levothyroxine | 36.72 (“difficult”) | (CI: 32.24 – 41.21) |
| Hashimoto’s Thyroiditis | 33.56 (“difficult”) | (CI: 29.15 – 37.97) |
| Hyperthyroidism | 33.44 (“difficult”) | (CI: 29.15 – 37.72) |